KEY PRODUCTS
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories
01 1CLOPIDOGREL BISULFATE FORM-II
01 1India
01 1Active
01 1Complete
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2022-02-15
Pay. Date : 2022-01-11
DMF Number : 35506
Submission : 2020-12-30
Status : Active
Type : II
20
Dr Reddys Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is CLOPIDOGREL BISULFATE FORM-II, with a corresponding US DMF Number 35506.
Remarkably, this DMF maintains an Active status since its submission on December 30, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 15, 2022, and payment made on January 11, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
